The NYLI MacKay High Yield Corporate Bond Fund’s underweight to lower-quality bonds contributed positively to returns over ...

The strategies that the industry’s lobbyists use, or don’t deploy, matter as the Trump administration moves more decisively against the industry than during his first term— pulling vaccine ...

Obesity rates for Black children and adolescents are 22.4% in the decade before the pandemic and 35% in the 2 years after the ...

Moderna’s experimental mRNA-based flu vaccine demonstrated a stronger immune response than a currently available standard flu shot in a late-stage phase 3 trial, clearing a path for regulatory ...

The FDA has announced a sweeping ban on Red Dye No. 3, giving food companies three years to reformulate their products.

The most read stories this past month detailed the passing of Dimitrios Karmpaliotis and news on Evoque and COVID-19.

Moderna said on Monday its influenza vaccine was found to be 26.6% more effective than an approved annual flu shot from GSK ...

The latest phase 3 win is a boost for Moderna’s attempts to create a flu/COVID combination vaccine. The company withdrew a filing for FDA approval for its combo candidate last month while it waited ...

Moderna in May voluntarily withdrew an application seeking approval of its combination shot targeting Covid-19 and influenza ... in the U.S., Hoge said Moderna is engaging closely with the FDA to ...

Some members of the scientific community have concern that they’re coming out of the COVID pandemic—exposure to the virus, ...

During his Senate confirmation hearings, Health Secretary Robert F. Kennedy Jr. suggested he wouldn’t undermine vaccines. “I ...

Experts said that COVID-19 vaccines are expected to be effective against this variant known as "nimbus." Here's what to know about it.